Amferia
Healthcare & Life Sciences
Recent Finacing
Equity
Recent Raise
$1.3M
Amferia is a Swedish medtech company developing hydrogel technology that uses antimicrobial peptides to combat resistant bacteria, with applications in wound care and medical implants.
Focus Areas
hydrogel technology
antimicrobial resistance
clinical development
commercialization
wound care
regulatory milestones
Investors
